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Ting-Ting Wang1†, Ran Zhang2†, Lin Wang1*, Yan Chen2, Qing Dong1 and Tie-Jun Li2,3,4*Abstract
Background: The clinicopathologic characteristics of multiple ossifying fibroma (OF) are unclear due to the
condition’s rarity, making diagnosis challenging. Sporadic multiple OFs must be distinguished from
hyperparathyroidism-jaw tumour syndrome (HPT-JT) related OF and other fibro-osseous lesions.
Methods: Multiple OF cases were identified from ossifying fibroma cases. Clinical data including age, sex, anatomic
site, radiographic features, clinical impression, treatment and available follow-up data as well as serum calcium,
phosphorus, and parathyroid hormone (PTH) were recorded. GNAS and HRPT2 genetic mutations were examined
in the two present cases. Case reports of sporadic multiple ossifying fibroma and HPT-JT-related OF were also
reviewed.
Results: The two present cases were confirmed as sporadic multiple OF, with no genetic GNAS and HRPT2
mutations found. The incidence of sporadic multiple ossifying fibroma was 2.0% (2/102). The total 18 sporadic
multiform OF cases were characterized as followed: 13 (72.2%) female; 5 (27.8%) male; mean age 28.6 years; 2/16
(11.1%) cases only in the mandible; 4/18 (22.2%) cases only in the maxilla; and 12/18 (66.7%) cases in both the
maxilla and mandible. Radiographically, the lesions were radiolucent in 5/18 (27.8%) cases and mixed density in
13/18 (72.2%) cases. Along with 24 cases of HPT-JT related OF were reviewed, sixteen (66.7%) patients were
diagnosed with a single lesion, and 8 patients (33.3%) were diagnosed with multiple jaw lesions.
Conclusions: Sporadic multiple OFs are very rare, but must be distinguished from HPT-JT related OF. We strongly
recommend that patients diagnosed with multiple ossifying fibromas receive serum PTH testing and mutation
screening of HRPT2.
Virtual slides: http://www.diagnosticpathology.diagnomx.eu/vs/1194507146115753
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Benign fibro-osseous lesions (BFOL) are a clinically diverse
group of bone disorders that share similar histologic fea-
tures and occur relatively commonly in the jaw. Common
to all forms of BFOL is the replacement of normal bone
with a tissue comprising collagen and fibroblasts containing
varying amounts of mineralized substance, which may be
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unless otherwise stated.developmental lesions, reactive or dysplastic processes,
and neoplasms [1,2]. Ossifying fibroma (OF), fibrous
dysplasia (FD), and osseous dysplasia (OD) are three
forms of BFOL. The most common OF lesions including
conventional and juvenile types that typically occur in
the premolar-molar region of the mandible, with women
more frequently affected [3]. OF is generally asymptom-
atic, but can cause serious cosmetic and functional prob-
lems [4]. Ossifying fibroma can present as a solitary lesion
or rarely, as multiple lesions.
OF and FD show distinct patterns of disease progression,
and it is important to distinguish between them. OF carries
a risk of recurrence and must be completely enucleated
from the surrounding bone. By contrast, FD growth usually
stabilizes when skeletal maturity is reached; hence, surgicaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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purposes [5-7]. However, these two lesions present diag-
nostic difficulties because of the uncertain significance
of specific radiological and histological features, especially
in biopsied specimens, and therefore, accurate diagnosis
can be challenging. WHO has suggested three subtypes of
fibrous dysplasia as follows: monostotic fibrous dysplasia
(MFD), which involves only one bone; polyostotic fibrous
dysplasia (PFD), which involves multiple bones; and
McCune-Albright syndrome (MAS), which has at least
two of the following triad: PFD, café-au-lait spots, and
hyperfunctional endocrinopathy (such as precocious
puberty, hyperthyroidism, growth hormone excess, and
Cushing’s syndrome). Multiple bone involvement is more
common in FD than in OF [2,8-10]. GNAS (guanine
nucleotide-binding protein/α-subunit) mutations that in-
duce the activation of G-protein α-subunit participate in
the pathogenesis of fibrous dysplasia. There is a well-
established association between fibrous dysplasia and
post-zygotic activating mutations of the GNAS gene
[11]. In a recent review by our group that updated the
GNAS genetic mutation rate of in fibrous dysplasia was
up to 86% (264/307), while no mutation was found in
patients diagnosed with ossifying fibroma [9]. GNAS
mutation detection may be helpful in differentiating fi-
brous dysplasia from other fibro-osseous lesions.
Hyperparathyroidism-jaw tumour syndrome (HPT-JT)
is an autosomal dominant, multiple neoplastic syndrome
primarily characterized by hyperparathyroidism caused
by a parathyroid adenoma or adenocarcinoma [12,13].
Kidney lesions may also occur in HPT-JT, including bilat-
eral cysts, renal hamartomas, or Wilms tumours. Benign
and malignant uterine tumours are apparently common in
women diagnosed with HPT-JT syndrome, including
adenomyosis, adenofibroma, endometrial hyperplasia,
leiomyoma, and adenosarcoma [14,15]. Recently, the
candidate tumor suppressor gene HRPT2 was identified
in chromosome 1q24-q32, enconding a novel protein of
531 amionacids named parafibromin [16]. Some studies
showed that alterations in HRPT2 gene are related with
HPT-JT and sporadic carcinoma and adenomas of para-
thyroid [9,17] Alterations in the tumor suppressor gene
HPRT2 in ossifying fibroma have recently been re-
ported. Direct sequencing of the HPRT2 revealed muta-
tions in two out of the four cases of ossifying fibroma.
However, one of the two mutational cases is HPT-JT
syndrome because of the increased PTH level [18].
These findings indicate that the HPRT2 mutation is not
common in the development of sporadic ossifying fi-
broma, and therefore may not be used as a marker for
diagnosis [5]. So when the HRPT2 gene revealed muta-
tions, the HPT-JT syndrome should be noticed. About
30–40% of individuals diagnosed with HPT-JT may also
develop single or multiple OFs, which are distinct fromthe “brown” tumours associated with severe hyperpara-
thyroidism [16,19,20]. Multiple OFs in patients diagnosed
with HPT-JT have been reported, but the ratio remains
unknown. Typically, OFs are encountered as solitary le-
sions in patients with no family history. Multiple ossifying
fibromas are rare, and only a few cases have been re-
ported. Here we report two cases of sporadic multiple OFs
with an emphasis on differential diagnosis between FD
and HPT-JT related OFs.
Materials and methods
Cases diagnosed as OF during 1949–2013 were re-
trieved from the medical records of the Department of
Oral Pathology, Peking University School of Stomatology.
The study protocol was approved by the Ethical Commit-
tee for Human Experiments of Peking University School
of Stomatology (IRB00001052-11041). Standard haema-
toxylin and eosin stained sections were reviewed, and
the lesions were reclassified according to the WHO
histological classification of odontogenic tumours [2].
Two cases of multiple OFs among 102 total confirmed
OF cases were identified. Clinical data including age,
sex, anatomic site, duration, radiographic features, clinical
impression, treatment, and available follow-up data were
reported. Mutational analysis of GNAS at the Arg201 and
Gln227 codons and screening of all HRPT2 exons were
performed on the tissue samples of the 2 cases using
direct sequencing. In addition, multiple OFs and HPT-




The patient was a 19-year-old female, with a chief com-
plaint of a slowly progressive, non-painful growth at the
left mandible. Four years previously, maxillary surgery
was performed at a local hospital on a lesion diagnosed
as an ossifying fibroma. There was no specified anam-
nesis or family history of neoplasia. On present examin-
ation, clinicians observed a mild facial asymmetry with a
hard swelling in the left mandible. The tumour was covered
by normal intact alveolar mucosa. Panoramic radiography
showed two well-demarcated bilateral radio lucencies in
the mandible. The left premolars were displaced slightly
due to extrusion, and the roots of two premolars were
resorbed (Figure 1A). Biochemistry blood tests showed
an elevated alkaline phosphatase of 278 IU/L (normal range
30–110 IU/L), but serum calcium and phosphorus were
normal. PTH was not tested in this patient. The lesions
were enucleated and easily from the surrounding bone.
Histologically, the lesions demonstrated interlacing
bundles of collagen fibres and cells associated with variable-
sized calcified tissue deposits (Figure 1B-C). The combination
of histopathologic, radiographic, and clinical features
Figure 1 Radiographic and histopathologic features of Case 1. (A) Panoramic radiograph showing two well-demarcated radiolucencies
bilaterally in the mandible. The right premolars were extruded and displaced, and the roots of two premolars were resorbed. (B-C) Haematoxylin
and eosin stain (100×) showing interlacing bundles of collagen fibres and spindle cells associated with variably sized calcified tissue deposits.
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sifying fibroma. Mutational analysis of GNAS and HRPT2
revealed no genetic abnormality in the lesion tissue sam-
ples. The lesions recurred one year after the first surgery,
but the patient refused further treatment.
Case 2
A 6-year-old boy had synchronous lesions involving both
the maxilla and mandible. His parents noticed the lesions
2 months prior to evaluation. The patient did not have any
familial history of jaw disease. On examination, the lesions
were firm and non-fluctuant, and bilateral mandibular buc-
cal bone expansion was found extending from the decidu-
ous canine to the deciduous molar. The overlying mucosa
was intact. Panoramic radiography revealed a large lesion
extending from the right ascending mandibular ramus to
the left ascending mandibular ramus. The lesion consisted
of a central heterogeneous mineralization and a thin
marginal radiolucent area with a well-demarcated sclerotic
border. Several tooth germs were displaced, and roots of
multiple primary teeth were resorbed. The permanentmolar teeth were significantly displaced, particularly the
second molar, which was displaced into the ascending
ramus (Figure 2A). A CT scan confirmed thinned bony
cortex of the inferior mandibular border and alveolar bone
expansion near the mixed radiopaque mass (Figure 2B).
A displaced tooth germ grew into the maxillary sinus
(Figure 2C). Blood tests (serum calcium, phosphorus,
alkaline phosphatase, and PTH) were within normal
limits. Incisional biopsies were performed in the man-
dibular and the maxillary lesions, and both specimens
showed a similar histopathologic pattern. The lesions were
mainly composed of fibrous tissue rich in fibroblasts with
spherical calcifications. The mandibular lesion showed
scarce areas of small spherical calcifications (Figure 2E);
by contrast, the maxillary specimen exhibited a larger
amount of these calcified structures (Figure 2F). The
combination of histopathologic, radiographic, and clinical
features supported a diagnosis of multiple conventional
ossifying fibroma. Mutational analysis of GNAS and
HRPT2 revealed no genetic abnormality in the lesions.
Because of the patient’s young age, the large size of the
Figure 2 Radiographic and histopathologic features of Case 2.
(A) Panoramic radiograph showing well-demarcated mixed-
density lesions surrounded by sclerotic border involving four
quarters of jaws. (B-C) CT scan demonstrating expansive lesions
involving in the maxilla and mandible. (D) After 1 year, the lesions
are visibly enlarged. (E) Haematoxylin and eosin stain (100×) of
the mandibular lesion showing scarce areas of small spherical
calcifications in dense fibroblasts. (F) Haematoxylin and eosin
stain (100×) showing a similar maxillary lesion of densely packed
fibroblasts and calcified structures.
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treatment was delayed, and the patient was closely
followed up for 1 year (Figure 2D).
Literature review of sporadic multiple ossifying fibroma
Based on a review of the literatures since 1968, together
with the present two cases, 18 cases (16 previously re-
ported cases [21-23]) of sporadic multiple ossifying fi-
broma were collected and summarized in Table 1. There
were 13(72.2%) female and 5 (27.8%) male patients, and
the mean age of the patients at initial diagnosis was
28.6 years old (range 6–55 years old). Bone swelling or
expansion was the typical clinical sign and occurred in
all patients. Two (11.1%) cases were found only in the
mandible, and 4 (22.2%) cases were found only in the
maxilla. Twelve (68.8%) cases were found in both the
maxilla and mandible. Radiographic findings included
unilocular and multilocular patterns demonstrating vary-
ing degrees of radiopacity in 5 cases (27.8%); radiolu-
cencies with well-circumscribed borders were also
found, and in 13 cases (72.2%), mixed density intrale-
sional calcification was observed. Among the 14 casesproviding therapeutic information, enucleation was the
primary treatment in 11 cases, and recurrence was docu-
mented in 3 cases (3/14) after 6 months, 1 year, and
2 years, respectively. Extended resection with an interpo-
sitional bone graft/titanium was performed in 2 cases,
and no recurrence was reported. Treatment in case 2
was delayed because of the patient’s young age, and the
lesion was closely monitored during follow-up. In the
previous 16 multiform OF cases, only 5 cases reported
the serum calcium and phosphorus, and only 2 cases
had special focus on the serum PTH.
Literature review of HPT-JT related OF
In total, 24 cases of HPT-JT related ossifying fibroma were
reviewed and are summarized in Table 2 [12,15,24-37]. Of
the 20 cases providing patient age and gender information,
6 patients were female, and 14 were male. The mean age
at initial diagnosis was 23.8 years old (range 13 years to
54 years). Sixteen (66.7%) patients were diagnosed with a
single lesion, and 8 patients (33.3%) were diagnosed with
multiple jaw lesions. Among the 16 cases of unilocular le-
sions, 12 cases were located in the mandible, and 4 were
in the maxilla; of the 8 multilocular cases, 2 were found
only in the mandible, 1 case was only in the maxilla, and 5
cases were found in both the maxilla and the mandible.
Discussion
The ratio of multiple lesions OF cases to all OF cases is
unclear, but we found only 2 cases in 102 case reviews
(2.0%). Only 16 known cases of multiple ossifying fibroma
have been reported (Table 1) [21-23,38-50]. Although the
patients were young in our two reported cases, the cases
are not considered juvenile ossifying fibromas (not psam-
momatoid or trabecular type) because of the histologic
features. The etiology and pathogenesis for both solitary
and multiple OF remain unknown. However, both forms
of OF present very similar clinical, radiologic, and histo-
pathologic features, suggesting that they are different clin-
ical presentations of the same disease [48].
According to the latest WHO classification, ossifying
fibroma and fibrous dysplasia can be distinguished in
the following manner. Radiologically, ossifying fibroma
is a well-demarcated lesion and does not merge with the
surrounding bone. Histopathologically, normal bone is
replaced by fibroblastic stoma with calcifications and
osteoblastic rimming observed [2,51]. However, the his-
topathologic characteristics of the two diseases may
overlap, making diagnosis difficult. Detection of GNAS
mutations is one valuable diagnostic adjunct [9]. Somatic
mutations at the Arg201 and Gln227 codon of Gsα have
been identified in many fibrous dysplastic lesions, but
are absent in ossifying fibromas, which points to a pos-
sible role for mutational analysis in differentiating these
two conditions [5,9,52,53]. In the present two cases, the
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F/6 Les. 1: rught maxilla
Les. 2: right angle
of the mandible









M/55 Les. 1: left maxilla
Les. 2: right maxilla
P.R: well-circumscribed lesions
showed radiolucent areas
mixed with radiopaque areas
N.S. N.S. N.S. Patient refused
treatment
N.S. N.S.
3 Hauser et al
[40], 1989
M/35 Les. 1: right
maxillary sinus




CT: well-circumscribed lesion with
calcified masses





4 Yih et al [41],
1989
F/31 Les. 1: left mandible
Les. 2: right maxilla
Les. 3: left mandible
(2 years later)
















M/33 Les. 1: right maxilla
Les. 2: left mandible





Both of the two
lesions: enucleation
Lost for follow-up N.S. N.S.
6 Hwang et al
[43], 2001
F/25 Les. 1: right
mandible
Les. 2: left maxilla
Les. 3: left mandibuar body
Les. 4: left maxilla
Les. 5: right maxilla
P.R.: large calcified mass
surrounded by a radiolucent halo
zone with corticated margin











7 Bertolini et al
[44], 2002




Les. 3: left mandible
P.R.: large radiolucency lesions with
interspersed calcifications
CT: revealed fibrous calcified masses
that involved the left maxilla and
the right and left mandibular body







2 y Maxilla.: no
recurrence after 1 y
N.S. N.S.
8 Barberi et al
[45], 2003
F/53 Les. 1: left
infraorbital region
Les. 2: right hard
palate
P.R.: showed partial opacification
of left maxillary sinus
CT: two different multilocular,
inhomogeneously hypodense
entities walled in an irregularly
thick sclerotic border
No /no N.S. N.S. N.S. N.S. N.S.
9 Stergiou et al
[46], 2007
F/36 Les. 1: left mandible
Les. 2: right mandible
Les. 3: left maxilla
P.R.: well circumscribed unilocular
radiolucency containing diffuse
calcifications
CT: well demarcated lesions,
low density and scattered
calcifications





10 Chindia et al
[47], 2008
F/27 Les. 1: right angle
and body of the
mandible
Les. 2: left maxilla
P.R.: mandibular lesion was
corticated and maxillary
lesion was less well defined
with almost complete obliteration
of the maxillary sinus




















Table 1 Summary of total 18 cases of sporadic multiple ossifying fibromas (Continued)
11 Ribeiro et al
[48], 2011
F/35 Les. 1: left mandible
Les. 2: right mandible
P.R.: large radiolucency
surrounded by a radiopaque
halo in the left and right mandible










12 Agarwal et al
[50], 2012
F/20 Les. 1: left posterior
maxilla
Les. 2: right posterior
mandible
P.R.: maxillary and mandibular
lesion was well-defined with a
radiolucent rim and sclerotic border
CT: hyperattenuated
masses in left maxillary and
right mandibular alveolar ridges




13 Popli et al
[21], 2012
F/19 Les. 1: left maxilla
Les. 2: right mandible
P.R.: well-defined mixed radiolucent
and radiopaque lesions
CT: mixed-density, expansile
lesions present at the alveolar process
of both the maxilla walled by ir







14 Akcam et al
[49], 2012
M/20 Les. 1: left maxilla
Les. 2: left mandible
P.R.: well defined,multilocular
radiolucent lesion of the left
mandible unilocular radiolucent
lesion in the left maxilla
CT: extensivehypodense
lesions with cortical expansion
Yes/no
Ca, P, PTH within
normal limits




et al [22], 2013
F/18 Les. 1: right maxilla
Les. 2: right mandible
CT: large well-defined expansile lesion,
heterogeneously hyper dense, multiple
internal punctuate calcifications




Enucleation No recurrence after
2 years
N.S. N.S.
16 Ponniah et al
[23], 2013
F/45 mutiple lesions from the left
mandible to the right
mandible
P.R.: multilocular radiolucent lesion
CT: osteolytic, soft-tissue density
lesion with thinning and erosion of
the buccal cortex in the anterior
region of the mandible
Yes/yes N.S. Enucleation No recurrence after
5 months
N.S. N.S.
17 Present case 1 F/15 Les.1: right maxilla
Les. 2, 3: bilateral mandible
P.R.: well demarcated radiolucency
in the bilateral mandible
Yes/yes Ca: 2.7 mmol/L
P: 0.77 mmol/L↓
ALP: 278 IU/L↑,




18 Present case 2 M/6 Les. 1: right maxilla
Les. 2: left maxilla
Les. 3: right mandible
Les. 4: left mandible
P.R.:central inhomogeneous
mineralizationin thin marginal
radiolucent area with a well
demarcated sclerotic border








because of the young
age




aF = female; M = Male.
bLes. = lesion.
cP.R. = panoramic radiograph; CT = Computerized Tomography.
dN.S. = not stated.
















Table 2 Cases of ossifying fiboma affected with HPT-JT in the literature
Number Author Age/gendera Single/multiple Location
1 Kutcher [24] 22/M Single The right posterior mandible
2 Iacobone [25] 26/F Single Left mandible ramus
3 Yamashita [15] 18/M Single Right maxilla
4 Raue [26] 29/M Single Mandible
5 Moon [27] 18/M Single Left mandible
6 17/F Single The right mandible
7 Teh [28] 26/M Single Left maxilla
8 Mallette [29] 36/N.S.* Single Maxilla
9 Rekik [30] 23/F Single The right body of the mandible
10 Dinnen [31] 18/M Single The right molar region of the mandible
11 Cavaco [32] 18/M Single Maxilla
12 31/M Single Mandible
13 23/M Single Mandible
14 21/F Single Mandible
15 Wamakulasuriya [36] 37/M Single The left mandible
16 43/M Single The left mandible
17 Teh [28] 54/M Multiple Lesion 1: mandible
Lesion 2: maxilla
18 Mallette [29] 17/N.S.* multiple Lesion 1: mandible
Lesion 2: hard palate
19 Schmidt [33] 37 M Multiple Lesion 1: right maxillary canine and premolar areas
Lesion 2: left maxillary canine and premolar areas
Lesion 3: left mandible
Lesion 4: right mandible
20 Szabo [34] 22/M Multiple Lesion 1: right maxilla
Lesion 2: in the right mandible
21 Howell [35] 16/M Multiple Lesion 1: right mandible
Lesion 2: right mandible
22 Aldred [12] 22/M Multiple Lesion 1 the right mandible
Lesion 2: the left mandible
23 Fujikawa [37] 22/F Multiple Lesion 1: left maxilla
Lesion 2:left mandible
Lesion 3: right mandible
24 Cavaco [32] 13/F Multiple Lesion1: maxilla
Lesion 2: mandible
aAge at first presentation, F = female, M = male, *N.S. = not stated.
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as tooth displacement and root resorption. Genetic
screening of the GNAS gene at Arg201 and Gln227
codon did not show any anomalies, which confirmed the
diagnosis of OF.
HPT-JT, considered a rare variant of familial HPT, was
first described in 1990 [14]. Hypercalcemia and high
PTH levels are associated with HPT-JT, andossifying fi-
bromas reportedly occur in 25–50% of HPT-JT cases[16,54]. We reviewed the literature reporting cases of
HPT-JT with jaw ossifying fibromas (Table 2). In the 24
identified cases, 16 (66.7%) cases were solitary lesions,
and 8 (33.3%) cases were multiple lesions. Thus, sporadic
multiple ossifying fibroma must be distinguished from cases
of HPT-JT. HPT-JT has been classically described as a
more aggressive disease characterized by multiple organ
involvement (45%–75%), increased risk of persistence and
recurrences (20%–50%), and parathyroid carcinoma
Wang et al. Diagnostic Pathology 2014, 9:75 Page 8 of 10
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is parathyroid gland resection, which prevents parathy-
roid carcinoma recurrence [55,56]. Differential diagno-
sis of ossifying fibroma associated with HPT-JT from
sporadic ossifying fibroma is important for treatment
and prognosis. In the cases reviewed, the serum cal-
cium and PTH levels were normal in case 2, allowing
us to exclude the association with HPT-JT. PTH was
not measured in case 1, but the patient had a normal
calcium level and no family history of HPT-JT. There-
fore, both cases were excluded from an association
with HPT-JT. In the previously reported 16 multiform
OF cases, only 5 cases had reported serum levels of cal-
cium and phosphorus, and only 2 cases reported the
serum PTH level; therefore, an association with HPT-
JT cannot be ruled out. HRPT2 genetic mutations are
associated with the hereditary pathogenesis of HPT-JT
syndrome [16]. Thus, HRPT2 genetic evaluation was
conducted in the present two cases, and showed no
mutational alternation. Based on the clinical and mo-
lecular findings, these two cases should be considered
sporadic, non HPT-JT cases.
There is another heterogeneous group of reactive BFOL
lesions, known as osseous dysplasia (OD); the lesions are
associated with the tooth apex and may be unifocal or
florid, involving most of the mandible [57]. The 2005
WHO classification divides ODs into focal, periapical, and
florid OD, and familial gigantiform cementoma [2]. Differ-
ential diagnosis between ossifying fibroma and osseous dys-
plasia is important. Radiographically, OD is diffuse and
amorphous, with mixed radiopaque to radiolucent lesions.
Histologic features include a cellular connective tissue
stroma punctuated by irregular osseous and/or cementum-
like calcifications [58]. According to the authors [58], the
criteria distinguishing OD from other fibro-osseous lesions
are: (1) a histologic pattern consisting of cellular mesenchy-
mal tissue with intermixed calcifications; (2) radiolucent
and/or radiopaque lesions in the jaws; (3) surgically, an eas-
ily fragmented, haemorrhagic, gritty mass difficult to re-
move from the bone; and (4) gross observations of multiple
haemorrhagic fragments of variable consistency. Osseous
dysplasia is thought to be non-neoplastic and originating
from the periodontal ligament [3]. Further surgical inter-
vention is not necessary for small lesions, but periodic
follow-up is recommended. Most OFs were not associated
with the tooth apex, but often caused divergence or dis-
placement of involved teeth [59]. Another rare heredi-
tary condition with radiographic and histologic features
similar to florid OD is familial gigantiform cementoma,
which tends to occur in early childhood or teenhood
[10]. Exuberant fibro-osseous lesions occurring in multiple
jaw quadrants were designated as gigantiform cemento-
mas or familial multiple cementomas in the first edition of
the WHO’s Histological Typing of Odontogenic Tumours,Jaw cysts, and Allied Lesions [60]. These lesions have also
been reported as familial florid cemento-osseous dysplasia
[61] and familial florid osseous dysplasia [62]. Although
cases with a familial pattern are noted in a few publica-
tions, sporadic cases without a family history have also
been reported [63]. Some authors suggested that these
cases were classified primarily as “ossifying fibroma” ra-
ther than “gigantiform cementoma” [64]. Compared to the
multiple ossifying fibroma, the clinicoradiologic features
are similar to those of florid osseous dysplasia: lesions sur-
rounding the root; an outer layer of dense opacities, and
multiquadrant, expansive, mixed radiolucent to opaque le-
sions crossing the jaw midlines. Microscopically dispersed
throughout the lesions are ovoid, often laminated, variably
sized psammomatoid calcifications. Many of these spher-
oidal calcifications are large, much larger than those ob-
served in the psammomatoid variant of ossifying fibroma
[1]. Under polarized light, Sharpy’s fibres are seen pro-
jecting radially from these larger spheroidal deposits
and resemble cementicles normally encountered in the
periodontal ligament [1].
Fibro-osseous lesions of the jaw and face must be dif-
ferentiated from other bone lesions that may mimic them
histologically and radiographically. The most important le-
sions in differential diagnosis are osteoblastoma, adamanti-
noma and giant cell granuloma. Osteoblastoma is a benign
radiolytic bone-forming neoplasm that is most common in
the postcranial skeleton, particular the posterior elements
of the spine, and it also may occur in the maxillofacial
region [65]. Histologically, the central differentiating cha-
racteristic is the lack of cellular spindle cells in the stroma,
which instead comprises loose vasculature with nume-
rous prominent epithelioid-type osteoblasts [57]. Nawal
Hammas’ recent study shows that P63 may serve as a
biomarker for the differential diagnosis between giant cell
tumor of bone and other morphologically similar lesions,
especially central giant cell granuloma since the latter does
not express P63 [66]. Adamantinoma is a primary low-
grade, malignant bone tumor that is predominantly
located in the mid-portion of the tibia. Histologically,
classic adamantinoma is a biphasic tumor characterized
by epithelial and osteofibrous components that may be
intermingled with each other in various proportions
and differentiating patterns [67]. Chondromyxoid fibro-
mas are rare benign chondroid/myxoid matrix-producing
tumors that occur in metaphyses of long tubular bones.
Prior cytogenetic analyses have identified complex abnor-
malities involving chromosome 6 in the majority of cases
and the cells can be positive for actin [68].
Conclusion
In conclusion, the suggested therapeutic approach for
HPT-JT is parathyroid gland resection to prevent oc-
currence of the parathyroid carcinoma. Differential
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sporadic ossifying fibroma is important for treatment and
prognosis. We presented 2 cases of multiple ossifying fi-
broma to illustrate to clinicians and radiologists that os-
sifying fibroma may have multiple forms and can be
linked to hereditary syndromes. Genetic screening of GNAS
could facilitate differential diagnosis of fibrous dysplasia at
the molecular level. Furthermore, we strongly recommend
that patients diagnosed with multiple or familial ossifying
fibromas receive serum tests for PTH and mutation screen-
ing of HRPT2, which could exclude possible association
with the HPT-JT syndrome.
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